

Omegametrix® provides a standardized analysis of 26 fatty acids in erythrocytes or whole blood, a method referenced in over 440 international publications. The results include the HS-Omega-3 Index® and the HS-Trans Index®, and more to come. Based on scientific data, the target range for the HS-Omega-3 Index has been defined to be between 8–11 %, and clinical effects are closely linked to this index. Due to the complex bioavailability of EPA and DHA, the use of omega-3 fatty acids is only safe and effective on the basis of the HS-Omega-3 Index.